A case of mesalamine potentiating hypoprothrombinemic effect of vitamin K antagonist (VKA) therapy resulting in life-threatening bleeding
PMID: 39660571
Source: J Postgrad Med
Publication date:
2025-07-24
Year:
2024
Abstract
NULL